Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 96.95
Key Takeaways
Risk factor
Weak & very vulnerable to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Shanghai MicroPort Endovascular MedTech Co., Ltd. develops, manufactures, and sells technologies and products in the healthcare business. The company primarily offers solutions for aortic and peripheral diseases. Its products include TAA and AAA stent graft systems, balloon inflation catheters, and PTA balloon dilatation catheters. The company was founded in 2012 and is based in Shanghai,...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Data is available to registered users only
Buy
Sell